CS Paper Radar

Multimodal-Conditioned Latent Diffusion Models for Spatiotemporal Brain MRI Forecasting

Antonio Scardace, Silvia Ingala, Sebastiano Battiato, Daniele Ravì

cs.CV cs.AI ·submitted 2026-10-18 19:09 UTC · v2
publishedcode/data

Abstract

Spatiotemporal forecasting of 3D anatomical changes is a critical generative vision challenge for modeling Alzheimer's Disease (AD) progression. While brain MRI forecasting from single-modality data has advanced, other key complementary multimodal biomarkers remain underutilized. In this work, we propose the Multimodal-Conditioned Latent Diffusion Model (MC-LDM), a novel framework for patient-specific brain MRI synthesis. MC-LDM leverages multimodal biomarkers---MRI, tau-PET, Clinical Dementia Rating (CDR), and APOE4---during training, but relies only on baseline MRI, APOE4, and patient metadata at inference, reflecting realistic clinical availability. Our contributions are threefold: (1) a Latent Diffusion Model (LDM) fine-tuned via Low-Rank Adaptation (LoRA) for data-efficient learning; (2) a multimodal conditioning that integrates molecular and clinical signals to model heterogeneous disease trajectories; and (3) auxiliary predictors estimating unobserved multimodal biomarkers from MRI features and patient covariates to condition the diffusion model, removing the need for these assessments at inference. Trained on 1,355 visits from 852 subjects in the Alzheimer's Disease Neuroimaging Initiative (ADNI), MC-LDM reduces average regional volumetric MAE by 18% over the second-best baseline on an independent test set of 664 visits. To our knowledge, MC-LDM represents the first diffusion-based framework to leverage multimodal priors for MRI forecasting. This conceptual advancement enables patient-specific trajectory generation that captures aspects of AD heterogeneity not observable from structural anatomy alone, bridging the gap between rich multimodal supervision and the strict constraints of routine clinical deployment. Code is available at: https://github.com/antonioscardace/MC-LDM.

Comment
Accepted to WACV 2027

Closest papers

Nearest neighbours by meaning across the whole index.

Covariate-Conditioned One-Step Diffusion for Multi-Horizon 3D Brain MRI Prediction in Aging and Neurodegeneration

eess.IV cs.AIcs.CVcs.LG ·2026-11-05 ·Natenaile Asmamaw Shiferaw, Ali Farki, Deepika Koundal, Jussi Tohka
code/data similarity 0.74
Abstract · 5 pages, 2 figures, 4 tables. Submitted to IEEE ISBI 2027

Predicting longitudinal brain changes from magnetic resonance imaging (MRI) can help characterize structural progression associated with aging and neurodegeneration. However, diffusion-based forecasting typically requires iterative denoising, limiting inference efficiency. We propose a covariate-conditioned one-step diffusion framework for multi-horizon prediction of 3D gray-matter density (GMD) maps. Rather than directly generating future anatomy, the model predicts longitudinal GMD changes through residual prediction in a single denoising step. The predicted changes are added to the baseline GMD map to reconstruct future anatomy. The model is conditioned on baseline anatomy, age, diagnosis, APOE4 allele count, and continuous follow-up time. Training combines mean squared error with a Pearson correlation loss to improve the spatial agreement between predicted and observed GMD changes. A unified model supports prediction horizons from 2 to 10 years. On the held-out ADNI test set, our method achieves a $Δ$-Pearson of 0.478, mean squared error (MSE) of $5.176 \times 10^{-3}$, and structural similarity index measure (SSIM) of 0.979, with $Δ$-Pearson reaching 0.582 at 10 years. Without retraining, external evaluation on AIBL yields a $Δ$-Pearson of 0.450, MSE of $4.016 \times 10^{-3}$, and SSIM of 0.985. Ablation studies further demonstrate the benefits of residual prediction, covariate conditioning, and correlation-based supervision. Code: https://github.com/natenaile/OneStepBrainMRI.

0.34

Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum

cs.LG cs.AIq-bio.QM ·2026-08-19 ·Yingying Zhang, Kun Zhao, Guodong Liu, Qi Huang, Pengfei Gu +8 more
similarity 0.73
Abstract

Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remain limited to discrete diagnosis or clinical score prediction from cross-sectional imaging. In this work, we propose Disease Continuum Positioning (DCP), a longitudinal Bayesian Learning framework that continuously estimates disease severity from longitudinal diffusion tensor imaging (DTI). Specifically, DCP models disease severity as a low-dimensional probabilistic latent variable by jointly integrating longitudinal observations with weak clinical supervision, from which the proposed Disease Continuum Score (DCS) is derived to quantify an individual's position along the Alzheimer's disease continuum together with its associated uncertainty. Extensive experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrate that DCP consistently outperforms representative disease progression methods. More importantly, comprehensive validation analyses show that DCS accurately characterizes disease severity, exhibits strong clinical relevance, preserves longitudinal disease evolution, and predicts future disease conversion. These results suggest that DCS provides a quantitative imaging-derived representation for continuous assessment of Alzheimer's disease progression beyond conventional diagnostic labels and clinical scores.

0.19

Clinical Pathways Matter for Multimodal Deep Learning in Early Alzheimers Disease Detection

eess.IV ·2026-08-17 ·Yao Lu, Solveig Kristina Hammonds, Alvaro Fernandez-Quilez
published similarity 0.71
Abstract · Published

Identifying individuals at risk of Alzheimer's disease (AD), particularly in the preclinical and early stages, remains challenging. Although deep learning approaches based on structural MRI show promise as a non-invasive biomarker, existing multimodal models require task-specific training and depend on biomarkers that are not routinely available in clinical practice. Here, we propose a zero-shot multimodal framework based on SigLIP that combines structural MRI embeddings with text embeddings of routinely collected clinical variables for early AD risk stratification in individuals at preclinical or mild cognitive impairment (MCI) stages. We evaluated the approach in 416 individuals from the ADNI cohort (age: 72.73 +- 6.7). SigLIP was used without fine-tuning to extract MRI and clinical text embeddings, which were combined into multimodal representations for individual-level AD risk prediction within 4 years. We further compared the model performance in a single-visit and two-visit settings to assess the value of longitudinal information and framework scalability. In the single-visit setting, combining MRI embeddings with MMSE, age, and sex achieved an AUC of 0.91 +- 0.02, outperforming both a CSF A\b{eta}42-based model (AUC 0.73 +- 0.08) and an MMSE-based model (AUC 0.85 +- 0.22). In the two-visit setting, performance was maintained or improved, supporting the scalability of the approach to longitudinal data. These findings suggest that zero-shot multimodal fusion of structural MRI and routinely collected clinical variables may provide a practical and scalable strategy for early AD risk stratification without task-specific retraining.

0.48

CoPoE: Multimodal Fusion via Decomposable Disease-Coordinate Product-of-Experts for Missing-Modality Alzheimer's Diagnosis

cs.LG cs.CV ·2026-10-08 ·Chihun An, Ikbeom Jang
publishedbenchmarkcode/data similarity 0.71
Abstract · Accepted at IEEE BIBM 2026

Multimodal Alzheimer's disease (AD) diagnosis benefits from integrating heterogeneous clinical, imaging, genomic, and biomarker evidence, but clinical cohorts frequently suffer from irregular modality missingness. Existing fusion methods often synthesize absent inputs, risking the introduction of artificial surrogates, or pool available signals into uninterpretable latent spaces. We present CoPoE (Disease-Coordinate Product-of-Experts), a disease-coordinate framework that maps multimodal evidence into a structured latent space partitioned into four distinct biological and clinical axes: genetic Risk, molecular Pathology, Neurodegeneration, and clinical Stage (R/P/N/S). Each observed modality parameterizes a diagonal Gaussian expert over the full RPNS vector, and a masked Product-of-Experts architecture fuses only the available modalities. Consequently, absent modalities add no factor to the fusion path, allowing the network to preserve a robust, decomposable posterior for any non-empty modality subset without synthetic imputation in the RPNS path. Through extensive missing-modality experiments on the ADNI dataset, CoPoE achieves the best all-modality performance and the highest mean AUROC across all 15 observed-subset evaluations among standardized missing-modality fusion baselines under a shared non-PET ADNI embedding benchmark, while substantially improving raw-probability ECE, Brier score, and NLL. Furthermore, PET-supervised probing shows evidence enrichment within the pathology (P) block under full modalities, with tau-related signal retained even when direct fluid biospecimen inputs are withheld. Our code is available at https://github.com/labhai/CoPoE.

0.44

dMRI-F: A Foundation Model for Generalizable Diffusion MRI Analysis from Sparse Acquisitions

cs.CV ·2026-10-13 ·Xi Zhu, Yijie Li, Xiaofan Wang, Wei Zhang, Huafu Chen +2 more
similarity 0.70
Abstract

Diffusion MRI (dMRI) probes water diffusion within the brain, providing unique information about tissue microstructure and white matter connectivity. High-quality dMRI enables advanced and accurate analyses but demands dense acquisitions, resulting in long scan times and hardware constraints that are often infeasible. Further, dMRI requires dedicated computational methods to support diverse analysis tasks (e.g., parcellation, registration, and synthesis) for both neuroscientific and clinical applications. Here, we present dMRI-F, a foundation model that unifies dMRI data enhancement and downstream tasks across diverse acquisitions and populations, while requiring only minimal acquisition input. dMRI-F is pre-trained with a q-space masked reconstruction task: predicting densely sampled multi-shell data from only six volumes. It learns generalizable latent feature representations of dMRI data, which serve as a core foundation for adapting to diverse downstream tasks, including brain parcellation, brain registration, and cross-modal synthesis. Across nine independently acquired datasets, we demonstrate that dMRI-F outperforms state-of-the-art methods with robust generalization across acquisitions, populations, and tasks. Our results demonstrate dMRI-F's versatility as a general-purpose framework that enables diverse dMRI applications from low-cost, sparse acquisitions.

0.15

Unified Multi-plane Autoregressive Diffusion for 3D Multi-contrast MRI Synthesis

cs.CV ·2026-10-07 ·Yejee Shin, Geonhui Son, Jinglu Wang, Minwoo Jung, Yan Lu +1 more
top venue similarity 0.70
Abstract · Accepted to ECCV 2026

Acquiring a complete set of magnetic resonance imaging (MRI) contrasts is time-intensive and uncomfortable for patients, despite the diagnostic value of multi-contrast imaging. This motivates synthesizing missing contrasts from those already acquired, which is an inherently 3D problem requiring anatomical coherence across axial, sagittal, and coronal planes. However, fully 3D generative models are often impracti- cal under computational resources that scale cubically with volume size. We propose a unified Multi-Plane Autoregressive Diffusion (MPAD), a latent diffusion framework that achieves full-volume 3D synthesis using efficient plane-wise 2D operations while preserving volumetric coherence. A 3D autoencoder first compresses MRI scans into an isotropic 3D la- tent representation. A 2D diffusion model is then trained to reconstruct masked latent slices of the target contrast, conditioned on both source- contrast slices and unmasked target-contrast slices. During inference, we introduce plane-wise autoregressive synthesis with inter-plane priors. Slices are generated autoregressively in random order within one plane orientation to maintain intra-plane continuity, then propagated as con- ditioning priors to orthogonal plane orientations to enforce inter-plane consistency. Compared to 3D latent diffusion baselines, MPAD reduces training and inference FLOPs by 7x and 3x, respectively, while also lowering inference time and peak memory consumption. Experiments on multiple datasets demonstrate that MPAD achieves superior perfor- mance, generating high-fidelity 3D volumes and supporting one-to-many translation within a single unified model.

0.33

M$^2$PFN: End-to-End Disentangled Alignment for Generalizable Multimodal In-Context Learning in Alzheimer's Disease

cs.CV cs.AIcs.LG ·2026-09-23 ·Lujia Zhong, Shuo Huang, Jianwei Zhang, Xinyu Nie, Yonggang Shi
similarity 0.70
Abstract · Under review

While various multimodal methods combining imaging and tabular data for Alzheimer's disease (AD) diagnosis were proposed, they are often limited in generalization across cohorts. In-context learning (ICL) has demonstrated excellent generalization performances and high flexibility in foundational tabular models such as TabPFN. To extend TabPFN's ICL to multimodal AD analysis, the main obstacle is that TabPFN is meta-trained on synthetic tabular priors that do not naturally match the statistical structure of image-derived features. We propose M$^2$PFN, an end-to-end framework that turns this tabular foundation model into a multimodal AD predictor. M$^2$PFN (i) performs differentiable inference through TabPFN's transformer, back-propagating task gradients into 3D-MRI and tabular encoders; (ii) aligns the two modalities into a shared subspace, via disentanglement and a contrastive objective, matched to the ICL engine's prior; and (iii) folds in a frozen tabular-only prediction through a learnable gated shortcut. Because the ICL engine stays frozen, its in-context mechanism is preserved for test-time generalization, while end-to-end training shapes the encoders into features it can exploit. On ADNI ($n=2240$, three-class CN/MCI/AD), M$^2$PFN attains $65.55\%$ macro-F1 and $82.21\%$ macro-AUC, surpassing a comprehensive set of unimodal and multimodal baselines. By swapping only the head for a TabPFN regressor, the same architecture regresses baseline MMSE on a $1250$-subject sub-cohort to test MAE $1.743$, outperforming every multimodal baseline. On two external cohorts (OASIS-3 and SCAN) with no retraining, M$^2$PFN achieves the best AUC and the lowest MMSE MAE across all baselines, and transfers even when the cognitive instrument changes.

0.12

Leakage-Controlled Multimodal Learning for Diagnosis and Progression Prediction in Alzheimer's Disease Research

cs.LG ·2026-10-07 ·Akeem Temitope Otapo, Ghazaleh Khodabandelou, Zuheng Ming, Alice Othmani
similarity 0.69
Abstract

Alzheimer's disease prediction involves irregular visits, heterogeneous measurements and incomplete modalities. This study presents a multimodal multitask framework combining an adapted SFCN MRI encoder, four causal clinical Transformers, shared fusion and task-specific ODE-GRU dynamics. Fine-tuning and LoRA adapt the final two MRI blocks. Task-DRO balances task losses, while Group-CVaR targets cohort and comorbidity strata. Branch-specific input controls, subject-grouped partitions and empirical causality checks support longitudinal evaluation. Across 2,649 subjects and 17,317 visits from ADNI, OASIS-2 and MIRIAD, internal validation yields diagnosis, stage-1 progression and first-stage-1-visit progression AUROCs of 0.935 +/- 0.002, 0.884 +/- 0.003 and 0.870 +/- 0.005, respectively (mean +/- SD across three seeds). Corresponding hybrid AUROCs are 0.951, 0.909 and 0.896. Next-visit MMSE mean absolute error (MAE) is 1.61 points; worst-stratum diagnosis AUROC is 0.827 +/- 0.008. Sampled ADNI explanations identify task-specific input dependence. OASIS-3 external validation yields network and hybrid diagnosis AUROCs of 0.763 and 0.767, hybrid next-visit progression AUROC of 0.764, diagnosis calibration error decreasing from 0.197 to 0.052, and next-visit MMSE MAE of 0.86. Seed-42 paired ablations of six components yield pooled diagnosis and progression AUROC differences between -0.004 and +0.004; removing clinical encoder inputs lowers diagnosis AUROC by 0.272. The framework integrates longitudinal prediction, missing-modality handling, auxiliary comorbidity modelling and subgroup evaluation within a common pipeline.

0.11